Physician profile
Mark Allen Mighell
NPI 1528065323
$4,299,174.90
in general payments reported to CMS, 2019-2025
38 companies · $587K in 2025
The $587K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $703K · 2020: $666K · 2021: $530K · 2022: $576K · 2023: $612K · 2024: $624K · 2025: $587K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.1M · Consulting Fee: $578K · Travel and Lodging: $73K · Food and Beverage: $27K · Education: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,144,049.60 |
| Consulting Fee | $577,855.00 |
| Travel and Lodging | $73,239.22 |
| Food and Beverage | $27,497.25 |
| Education | $504.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,764,091.19 | 2019-2025 | Reunion, Blueprint Patient Specific Instrumentation, Aequalis Perform |
| Encore Medical, Lp | $464,800.54 | 2019-2025 | Djo Surgical |
| Wright Medical Technology, INC. | $32,672.74 | 2019-2020 | |
| Medical Device Business Services, INC. | $14,829.06 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $6,128.76 | 2020-2025 | Mymobility Platform |
| Pacira Pharmaceuticals Incorporated | $5,694.39 | 2019-2025 | Exparel |
| Mvp Orthopedics INC | $2,610.06 | 2019-2022 | |
| Coastal Medical Technologies LLC | $1,570.29 | 2023-2025 | |
| Dunamis Medical, LLC | $1,530.66 | 2023-2025 | |
| Depuy Synthes Sales INC. | $1,030.56 | 2019-2025 | Healix Knotless Peek |
| Smith+Nephew, INC. | $914.11 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Pico 14, Renasys Go V2 Home |
| Baxter Healthcare | $484.27 | 2023-2025 | Floseal, Tisseel |
| Arthrex, INC. | $418.20 | 2025 | |
| Sanara Medtech INC. | $354.14 | 2024-2025 | Celleraterx, Celleraterx, Biasurge |
| Orthofix Medical, INC. | $245.36 | 2022-2025 | Physio-Stim |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossur Americas, INC. | $225.42 | 2024 | Miami J |
| Biorez, INC. | $187.35 | 2022 | |
| Heron Therapeutics, INC. | $170.45 | 2021-2025 | Zynrelef |
| Ethicon US, LLC | $136.50 | 2020-2024 | Vistaseal, Surgiflo Hemostatic Matrix |
| Bioventus LLC | $133.69 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Exactech, INC. | $125.46 | 2023 | |
| Trice Medical, INC. | $123.93 | 2022-2023 | |
| Horizon Therapeutics Plc | $107.19 | 2019 | |
| Medtronic, INC. | $94.89 | 2021-2025 | Aquamantys(Tm) |
| Anika Therapeutics, INC. | $94.81 | 2023 | Ovomotion |
| Davol INC. | $70.39 | 2025 | Surgiphor |
| Biocomposites INC | $53.85 | 2019 | |
| Restor3d, INC. | $52.60 | 2024 | |
| Biedermann Motech, INC. | $43.08 | 2019 | |
| Abbott Laboratories | $38.67 | 2022 | |
| Coopersurgical, INC. | $32.21 | 2019 | |
| Convatec INC. | $29.01 | 2021 | |
| Heraeus Medical, LLC. | $19.55 | 2023 | Palacos |
| Fx Shoulder Solutions, INC | $19.00 | 2019 | |
| Acera Surgical, INC. | $18.62 | 2023 | Restrata Wound Matrix |
| Amgen INC. | $13.21 | 2024 | Krystexxa |
| Arthrosurface Incorporated | $10.69 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$31,895.79 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mighell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.